These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29925179)

  • 1. [Myocardial amyloid deposition in patients aged over 85 years with heart failure and preserved ejection fraction].
    Li YY; Zhu WR; Chai K; Yang JF; Fang F; He SR; Yang CQ; Wang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jun; 46(6):438-443. PubMed ID: 29925179
    [No Abstract]   [Full Text] [Related]  

  • 2. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.
    Mohammed SF; Mirzoyev SA; Edwards WD; Dogan A; Grogan DR; Dunlay SM; Roger VL; Gertz MA; Dispenzieri A; Zeldenrust SR; Redfield MM
    JACC Heart Fail; 2014 Apr; 2(2):113-22. PubMed ID: 24720917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathological study on the relationship between nucleic acid oxidative stress and heart failure with preserved ejection fraction in patients aged over 85 years].
    Zhu WR; Chai K; Fang F; He SR; Li YY; Du MH; Li JJ; Yang JF; Cai JP; Wang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Oct; 51(10):1063-1068. PubMed ID: 37859358
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathological characteristics of the heart and coronary artery from elderly heart failure patients with preserved ejection fraction and coronary artery disease].
    Chai K; Wang H; Li YY; Luo Y; Fang F; Liu DG; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):710-715. PubMed ID: 28851190
    [No Abstract]   [Full Text] [Related]  

  • 6. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction:
    Aikawa T; Naya M; Obara M; Oyama-Manabe N; Manabe O; Magota K; Ito YM; Katoh C; Tamaki N
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1897-1905. PubMed ID: 28653180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
    Ravassa S; Trippel T; Bach D; Bachran D; González A; López B; Wachter R; Hasenfuss G; Delles C; Dominiczak AF; Pieske B; Díez J; Edelmann F
    Eur J Heart Fail; 2018 Sep; 20(9):1290-1299. PubMed ID: 29709099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis.
    Hahn VS; Yanek LR; Vaishnav J; Ying W; Vaidya D; Lee YZJ; Riley SJ; Subramanya V; Brown EE; Hopkins CD; Ononogbu S; Perzel Mandell K; Halushka MK; Steenbergen C; Rosenberg AZ; Tedford RJ; Judge DP; Shah SJ; Russell SD; Kass DA; Sharma K
    JACC Heart Fail; 2020 Sep; 8(9):712-724. PubMed ID: 32653448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction.
    Carluccio E; Biagioli P; Zuchi C; Bardelli G; Murrone A; Lauciello R; D'Addario S; Mengoni A; Alunni G; Ambrosio G
    Int J Cardiovasc Imaging; 2016 Jul; 32(7):1071-80. PubMed ID: 27076221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction-Profibrotic and Proinflammatory Pathways and Genes.
    Ye B; Bradshaw AD; Abrahante JE; Dragon JA; Häußler TN; Bell SP; Hirashima F; LeWinter M; Zile MR; Meyer M
    Circ Heart Fail; 2023 Aug; 16(8):e010395. PubMed ID: 37582166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
    Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
    Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction.
    Lo Presti S; Horvath SA; Mihos CG; Rajadhyaksha C; McCloskey V; Santana O
    Crit Pathw Cardiol; 2019 Dec; 18(4):195-199. PubMed ID: 31725511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
    Zile MR; Baicu CF; Ikonomidis JS; Stroud RE; Nietert PJ; Bradshaw AD; Slater R; Palmer BM; Van Buren P; Meyer M; Redfield MM; Bull DA; Granzier HL; LeWinter MM
    Circulation; 2015 Apr; 131(14):1247-59. PubMed ID: 25637629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.
    Runte KE; Bell SP; Selby DE; Häußler TN; Ashikaga T; LeWinter MM; Palmer BM; Meyer M
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28784688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia.
    Nojima Y; Ihara M; Kurimoto T; Nanto S
    Am J Case Rep; 2016 Apr; 17():235-40. PubMed ID: 27064109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.